Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...

Curium Pharma, a developer, manufacturer, and distributor of nuclear medicine, has acquired Eczacıbaşı-Monrol Nuclear ...

Merck has shared data from the pivotal Phase 3 trial evaluating the subcutaneous administration of pembrolizumab together ...

3D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision ...

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

National Resilience Inc., a technology-focused biomanufacturing company, is initiating the next phase of its growth in the ...

Linearis has inaugurated a new laboratory in the greater Quebec City region and introduced its high-throughput metabolomics ...